Defining Risk of Late Recurrence in Early-Stage Estrogen Receptor-Positive Breast Cancer: Clinical Versus Molecular Tools - PubMed (original) (raw)
. 2019 Jun 1;37(16):1365-1369.
doi: 10.1200/JCO.18.01933. Epub 2019 Apr 3.
Affiliations
- PMID: 30943126
- DOI: 10.1200/JCO.18.01933
Defining Risk of Late Recurrence in Early-Stage Estrogen Receptor-Positive Breast Cancer: Clinical Versus Molecular Tools
Julia Foldi et al. J Clin Oncol. 2019.
No abstract available
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical